Jones Financial Companies’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Jones Financial Companies’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$801K	Buy	6,749 +185	+3%	+$20K	﹤0.01%	2006
2026 Q1	$655K	Buy	6,564 +302	+5%	+$31.9K	﹤0.01%	1910
2025 Q4	$655K	Buy	6,262 +2,204	+54%	+$222K	﹤0.01%	1398
2025 Q3	$370K	Buy	4,058 +1,075	+36%	+$94.1K	﹤0.01%	1520
2025 Q2	$238K	Buy	2,983 +373	+14%	+$29.8K	﹤0.01%	1587
2025 Q1	$220K	Buy	2,610 +434	+20%	+$37K	﹤0.01%	1462
2024 Q4	$180K	Buy	2,176 +1,440	+196%	+$124K	﹤0.01%	1400
2024 Q3	$63.4K	Buy	736 +42	+6%	+$3.59K	﹤0.01%	1558
2024 Q2	$57K	Buy	+694	New	+$55.1K	﹤0.01%	1204

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Jones Financial Companies's PJP Position: Q2 2026 in Review

Jones Financial Companies increased its Invesco Pharmaceuticals ETF (PJP) stake by 2.8% in Q2 2026, buying an estimated $20K and bringing the position to 6,749 shares worth $801K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Jones Financial Companies first reported a position in PJP in Q2 2024 and has held it in 9 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Jones Financial Companies held 6,749 shares of Invesco Pharmaceuticals ETF worth $801K as of Q2 2026.
Jones Financial Companies bought 185 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $20K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2006 holding.
Jones Financial Companies first reported a position in Invesco Pharmaceuticals ETF in Q2 2024 and has held it in 9 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.